Table 2 Results of CD4 + T cells and viral load within the 48 months second-line antiretroviral treatment
Duration of treatment (month) | Patients followed-up (n) | Viral load (lg10) (median, IQR) copies/ml | Viral load compared with baseline | CD4 + T cells (median, IQR) cells/μl | CD4 compared with baseline |
|---|---|---|---|---|---|
Baseline | 120 | 4.58(3.96–5.17) | – | 170(100–272) | – |
6 | 102 | 2.02(1.00–3.84) | P < 0.001 | 230(164–323) | P < 0.001 |
12 | 104 | 1.60(1.00–3.38) | P < 0.001 | 246(185–349) | P < 0.001 |
18 | 82 | 1.77(1.00–3.87) | P < 0.001 | 296(186–394) | P < 0.001 |
24 | 90 | 1.70(1.00–3.90) | P < 0.001 | 316(205–436) | P < 0.001 |
48 | 85 | 1.00(1.00–3.15) | P < 0.001 | 359(236–501) | P < 0.001 |